Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chung King, Choi"'
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145994 (2015)
Phorbol esters, which are protein kinase C (PKC) activators, and histone deacetylase (HDAC) inhibitors, which cause enhanced acetylation of cellular proteins, are the main classes of chemical inducers of Epstein-Barr virus (EBV) lytic cycle in latent
Externí odkaz:
https://doaj.org/article/bf5d5cd890534242ae53f89f4650b44b
Autor:
Dan Yang, Chung King Choi, Alan K. S. Chiang, Richard Y.T. Kao, Stephanie Pei Tung Yiu, Chi Wang Ma, Kwai Fung Hui
Publikováno v:
Cancers, Vol 10, Iss 12, p 505 (2018)
Cancers
Volume 10
Issue 12
Cancers
Volume 10
Issue 12
Pharmaceutical reactivation of lytic cycle of Epstein&ndash
Barr virus (EBV) represents a potential therapeutic strategy against EBV-associated epithelial malignancies, e.g., gastric carcinoma (GC) and nasopharyngeal carcinoma (NPC). A novel lyt
Barr virus (EBV) represents a potential therapeutic strategy against EBV-associated epithelial malignancies, e.g., gastric carcinoma (GC) and nasopharyngeal carcinoma (NPC). A novel lyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e021d9a7e76ed7e417d79b0ccd5151e8
https://www.mdpi.com/2072-6694/10/12/505
https://www.mdpi.com/2072-6694/10/12/505
Autor:
Maria Li Lung, Chung King Choi, Kwai Fung Hui, Jaap M. Middeldorp, Sai Wah Tsao, Alan K. S. Chiang, Po Ling Yeung, Arthur Kwok Leung Cheung
Publikováno v:
International Journal of Cancer. 138:125-136
Pan-histone deacetylase (HDAC) inhibitors, which inhibit 11 HDAC isoforms, are widely used to induce Epstein-Barr virus (EBV) lytic cycle in EBV-associated cancers in vitro and in clinical trials. Here, we hypothesized that inhibition of one or sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d87d423965650f15a02b6befa86b9c8
https://doi.org/10.1002/ijc.29698
https://doi.org/10.1002/ijc.29698
Autor:
Kwai Fung, Hui, Arthur Kwok Leung, Cheung, Chung King, Choi, Po Ling, Yeung, Jaap M, Middeldorp, Maria Li, Lung, Sai Wah, Tsao, Alan Kwok Shing, Chiang
Publikováno v:
International journal of cancer. 138(1)
Pan-histone deacetylase (HDAC) inhibitors, which inhibit 11 HDAC isoforms, are widely used to induce Epstein-Barr virus (EBV) lytic cycle in EBV-associated cancers in vitro and in clinical trials. Here, we hypothesized that inhibition of one or sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::85368c1d4d4a2b4b1b455ac22f9bf9f2
https://pubmed.ncbi.nlm.nih.gov/26205347
https://pubmed.ncbi.nlm.nih.gov/26205347
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 12, p e0145994 (2015)
PLoS ONE, Vol 10, Iss 12, p e0145994 (2015)
Phorbol esters, which are protein kinase C (PKC) activators, and histone deacetylase (HDAC) inhibitors, which cause enhanced acetylation of cellular proteins, are the main classes of chemical inducers of Epstein-Barr virus (EBV) lytic cycle in latent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea9585a036a7d42261ddef13a6784f3
https://doi.org/10.1371/journal.pone.0145994
https://doi.org/10.1371/journal.pone.0145994